Perinatal diagnosis of malignant hyperthermia susceptibility [12]

Anaesthesia and Intensive Care

Volumn 35, Issue 3, 2007, Pages 454-455

  Stowell, K ^a   Pollock, N ^a   Langton, E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; CONTAMINATION; DELIVERY; DNA SEQUENCE; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LETTER; MALIGNANT HYPERTHERMIA; MATERNAL BLOOD; MUSCLE BIOPSY; NEWBORN ASSESSMENT; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; UMBILICAL CORD BLOOD;

ALLELES; DISEASE SUSCEPTIBILITY; FETAL BLOOD; HUMANS; INFANT, NEWBORN; MALIGNANT HYPERTHERMIA; MUTATION; POLYMERASE CHAIN REACTION;

EID: 34250686672     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Urwyler A, Deufel T, McCarthy T, West S. Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth 2001; 86:283-287.
2. Girard T, Treves S, Voronkov E, Siegemund M, Urwyler A. Molecular genetic testing for malignant hyperthermia susceptibility. Anesthesiology 2004; 100:1076-1080.
3. Weber M, Hagege H, Lutfalla G, Dandolo L, Brunel C, Cathala G et al. A real-time polymerase chain reaction assay for quantification of allele ratios and correction of amplification bias. Anal Biochem 2003; 320:252-258.